David Mizrahi

Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy

David Mizrahi, Susanna B. Park, Tiffany Li et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Oncology, Pharmacology +15

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response.

Olivier Ernst, Géraldine Sergent, David Mizrahi et al. · American Journal of Roentgenology · 1999 · 107 citations · Full text

Medicine, Oncology, Surgery +10

Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer

Tejaswi Kandula, Michelle A. Farrar, Richard J. Cohn et al. · JAMA Neurology · 2018 · 104 citations · Full text

Medicine, Neurology, Oncology +16

An Exercise Intervention During Chemotherapy for Women With Recurrent Ovarian Cancer

David Mizrahi, Carolyn Broderick, Michael Friedländer et al. · International Journal of Gynecological Cancer · 2015 · 57 citations

Medicine, Oncology, Chemotherapy +16

Barriers and enablers to physical activity and aerobic fitness deficits among childhood cancer survivors

David Mizrahi, Claire E. Wakefield, David Simar et al. · Pediatric Blood & Cancer · 2020 · 44 citations · Full text

Education, Oncology, Exercise Testing +16